Clincosm LogoSign in Get a demo

AML

Showing NaN - NaN of 9
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

AML, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in United States (APG-115, 5-azacitidine)

Recruiting
  • AML
  • +6 more
  • Gilbert, Arizona
  • +7 more
Jul 8, 2022

AML Trial in Worldwide (Flotetuzumab dose escalation, Flotetuzumab dose expansion, Ruxolitinib)

Active, not recruiting
  • AML
  • Flotetuzumab dose escalation
  • +2 more
  • Duarte, California
  • +42 more
Mar 7, 2022

AML Trial in Puerto Rico, United States (Cytarabine (Phase 1 only), Lintuzumab-Ac225, Furosemide (Phase 1 only))

Completed
  • AML
  • Cytarabine (Phase 1 only)
  • +3 more
  • Los Angeles, California
  • +16 more
Feb 22, 2022

Leukemia, Myeloid, Acute, AML Trial in United States (PTC299)

Terminated
  • Leukemia, Myeloid, Acute
  • AML
  • Aurora, Colorado
  • +16 more
Jan 18, 2022

MDS, CMML, AML Trial in Canada, United States (SGI-110)

Completed
  • MDS
  • +2 more
  • Scottsdale, Arizona
  • +15 more
Apr 16, 2021

AML Trial in Worldwide (Quizartinib, Salvage Chemotherapy)

Completed
Has Results
  • AML
  • Duarte, California
  • +130 more
Feb 2, 2021

Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Blast-phase Chronic Myelogenous Leukemia Trial in Tampa, Baltimore, Durham

Completed
  • Acute Myeloid Leukemia
  • +5 more
  • STA-9090 (ganetespib)
  • Tampa, Florida
  • +2 more
Sep 17, 2014

Hematologic Malignancies, AML Trial in Worldwide (CP-4055)

Completed
  • Hematologic Malignancies
  • AML
  • Valhalla, New York
  • +15 more
Sep 12, 2013

Acute Myeloid Leukemia, AML Trial in Canada, Netherlands, United States (Tosedostat)

Completed
  • Acute Myeloid Leukemia
  • AML
  • Los Angeles, California
  • +20 more
Jun 27, 2012